The Society of Thoracic Surgeons (STS)

01/23/2025

Paid Ad - Cardiac surgeries face a 10.8% SSI rate. PICO sNPWT may help reduce surgical site complications by up to 70% following coronary artery bypass graft (CABG) surgery. 1 The proof is in the data. PICO sNPWT is designed to minimizes risks and maximizes outcomes.
Explore how PICO sNPWT can elevate your outcomes today!

Learn More
https://possiblewithpico.com/treatment-utilizing-pico-snpwt

11/12/2024

Have you listened to STS's "Thinking Thoracic" podcast yet? Tune in today! https://ow.ly/pc3K50U5a80

11/10/2024

In the latest issue of STS News, our members-only digital magazine, learn how a multidisciplinary group of experts developed a new consensus definition for resectability in locally advanced non-small cell lung cancer (NSCLC). The process included a thorough review of the literature and employed a modified Delphi method, focusing on critical areas such as resectability, neoadjuvant therapy, and adjuvant therapy. "This document provides clinicians with a valuable tool to offer more comprehensive, personalized treatments for patients with locally advanced NSCLC," said Samuel Kim, MD, of Northwestern Medicine. Read more now: https://ow.ly/Tlv950U0OAy

11/09/2024

It's . Join us on Nov. 15 for Latin Thoracic Rounds: Rounds on a Patient with Locally Advanced Stage Lung Cancer, where an international panel of experts will discuss will discuss diagnosis, neoadjuvant and adjuvant treatments, restaging, and surgical approach and complications. This free webinar will be presented in Spanish with English subtitles. Learn more here. https://ow.ly/OfJS50U1FR8

11/07/2024

Take a look at this Cardiovascular Business article which reports on a new analysis published in The Annals of Thoracic Surgery showing advanced robotics to guide SAVR procedures may be a safe alternative to TAVR in low- and intermediate-risk patients with severe aortic stenosis. The researchers found that “TAVR was...linked to significantly higher rates of permanent pacemaker implantation (7.6% vs. 2.1%), vascular complications (9% vs. 0%) and stroke events (4.2% vs. 0.7%) than RAVR.” Read more: https://ow.ly/AbIu50U1AuH

Robotic-assisted aortic valve surgery may be a safe, effective alternative to TAVR when treating low- and intermediate-risk patients. A new analysis in The Annals of Thoracic Surgery explored this topic at length.

11/06/2024

The Thinking Thoracic podcast is here! In our premiere episode, podcast host Dr. Erin Gillaspie, of CHI Health, speaks with Dr. Wade Iams, of Vanderbilt University Medical Center, about the latest lung cancer clinical trials from the World Conference on Lung Cancer. Tune in today: https://ow.ly/Plpb50U0S1l

11/04/2024

We’re just 2 days away from the "Thinking Thoracic" podcast launch on November 6! Stay at the forefront of thoracic surgery advancements with our new podcast. Each episode features leading voices in the field discussing the latest research, innovative surgical techniques, and key trends shaping the future of thoracic care. Whether you're a seasoned surgeon or a healthcare professional looking to expand your knowledge, this podcast is for you. Listen this Wednesday. https://ow.ly/YJjS50TZEiZ

11/03/2024

A new clinical trial suggests that patients with failing heart valves could be better off with early surgery rather than a “wait and see” treatment plan. According to a The New York Times article, “The trial…could change the way doctors treat severe aortic stenosis…”. https://ow.ly/ATJw50TYctP

The results of a new clinical trial have overturned the “wait and see” approach that cardiologists have long favored for symptom-free patients.

11/01/2024

This , we are excited to kick off November by celebrating the achievements of our CT surgeons. Their efforts have led to groundbreaking advancements in lung cancer treatments. Through collaboration, expertise, and a commitment to shared goals, they have significantly improved patient outcomes and positioned us at the forefront of our specialty. Their dedication to driving innovation, enhancing patient care, supporting research, and promoting technology have made a profound impact on the field. Learn more: https://ow.ly/AT6x50TXzqY

10/31/2024

In this STS blog article, Global Differences in Managing Patients with Aortic Valve Disease, by Dr. A. Sampath Kumar from New Delhi, India, read about the enormous disease burden facing marginalized regions around the world where people with aortic valve disease need surgery, but cost and access to specialized treatment are significant barriers. Dr. Kumar explains, “Access to specialized cardiac care is limited in many low-income countries. But a global initiative is attempting to assist low- and middle-income nations to develop facilities for the diagnosis and management of heart disease, in particular valvular diseases.” Learn more. https://ow.ly/W6RN50TWKC6